We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Getein Biotech, Inc.

Getein Biotech, Inc. is a fully integrated in vitro diagnostic company that develops, manufactures and distributes an... read more Featured Products: More products

Download Mobile App





Getein Biotech Exhibits Advanced POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)
Image: The Metis 6000 Modular System is being highlighted at MEDICA 2023 (Photo courtesy of Getein)

Getein Biotech, Inc. (Nanjing, China) is exhibiting its range of advanced analyzers for point-of-care testing at MEDICA 2023.

At the MEDICA show, visitors to the Getein booth can experience its unique products and services first-hand that deliver efficient diagnostic and treatment solutions, helping healthcare professionals increase efficiency, reduce costs, and deliver a better patient experience. Getein is highlighting its Metis 6000 Modular System (Integrated Clinical Chemistry and Immunochemistry) that helps labs unlock efficiency and optimize space. The Metis 6000 Modular System comprises the MAGICL 6200 immunochemistry module with a throughput of up to 400 T/H, the CM-1000 clinical chemistry module with a throughput of up to 1000 T/H, and the SHC 200 pre-analytical module (optional) with a speed of 190 tubes/H.

Getein is also showcasing the Metis 600 Modular System (Integrated Immunofluorescence and Hematology) which provides a suitable solution for immunofluorescence and hematology testing in low-volume laboratories. The Metis 600 Modular System comprises the Getein 1200 immunofluorescence quantitative analyzer and the BHA-5100 automatic hematology analyzer. The combination of immunofluorescence and hematology methodologies allows for more comprehensive test items to be offered. Also on display at MEDICA 2023 is the BHA-5000 automatic 5-part differential hematology analyzer which uses laser-based flow cytometry to count white blood cells in blood samples. It also uses electrical impedance to count red blood cells and platelets, and colorimetry to measure the hemoglobin, and relevant parameters will be enumerated.

In addition, Getein is exhibiting the MAGICL 6000 chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that require a one-step chemiluminescence solution. Alongside MAGICL 6000 was the Getein 1600 fully-automated immunofluorescence quantitative analyzer which combined with bar-coded, ready-to-use strip cassettes, delivers accurate testing results in minutes. The company is demonstrating the Getein 208 hand-held integrated system which is intended to detect and quantify specific chemical components in human blood serum, plasma, whole blood, capillary blood, and urine samples through dry chemistry and fluorescence immunoassay. Visitors to the company’s booth can learn about Getein’s POCT test menu which includes a wide range of reagent options, covering rapid testing for various diseases and health indicators.

Related Links:
Getein Biotech, Inc. 

New
Gold Member
Troponin T QC
Troponin T Quality Control
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Pregnancy Test
CLINITEST hCG
New
Respiratory Syncytial Virus Test
QuickVue RSV Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The Accelerate Arc System has been granted US FDA 510(k) clearance (Photo courtesy of Accelerate Diagnostics)

Automated Positive Blood Culture Sample Preparation Platform Designed to Fight Against Sepsis and AMR

Delayed administration of antibiotics to patients with bloodstream infections significantly increases the risk of morbidity and mortality. For optimal therapeutic outcomes, it is crucial to rapidly identify... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: Last year, Seegene and Werfen has entered into a collaboration on the OneSystem business to develop syndromic qPCR assays (Photo courtesy of Seegene)

Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative

Seegene (Seoul, South Korea), a leading PCR molecular diagnostics company, and Werfen (Barcelona, Spain), a global diagnostics specialist, have finalized a partnership agreement as part of a technology-sharing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.